TrialThe New England journal of medicine2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Patrick M Forde et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,202 papers cite itlatest 60 shown
this paperpooled ittrialcites it